期刊文献+

临床药师对妇科术后并发急性肺栓塞患者的药学监护

Pharmaceutical care for patients with acute pulmonary embolism after gynecologic surgery by clinical pharmacists
下载PDF
导出
摘要 目的:探讨临床药师对妇科术后并发急性肺栓塞患者的药学监护作用。方法:临床药师参与1例妇科手术后并发急性肺栓塞的抗凝治疗,根据患者病情变化情况,提出用药建议,调整用药剂量,并对患者进行全程药学监护。结果:患者经抗凝治疗后症状得到好转,各项检查指标基本恢复至正常范围。结论:临床药师积极参与临床治疗,发挥专业特长,为临床医生提供用药建议,以保证患者用药安全和有效。 Objective:To explore the role of clinical pharmacists in the pharmaceutical care for patients with acute pulmonary embolism after gynecological surgery.Methods:Clinical pharmacist participated in the anticoagulant treatment of a case of patient with acute pulmonary embolism complicated by gynecological surgery and made recommendations for medication and dosage and provided full pharmaceutical care for the patient throughout the whole process based on the changes of the patient’s conditions.Results:After anticoagulant therapy,the symptoms of the patients were improved and all the indexes were basically returned to the normal range.Conclusion:Clinical pharmacists actively participate in clinical treatment,give full play to their professional expertise,and provide drug recommendations to clinicians so as to ensure the safety and effectiveness of drug use.
作者 黄亭 王先利 HUANG Ting;WANG Xianli(Department of Pharmacy,Obstetrics and Gynecology Hospital,Fudan University,Shanghai 200090,China;Department of Pharmacy,Xuzhou Maternal and Child Healthcare Hospital,Xuzhou 221000,China)
出处 《上海医药》 CAS 2022年第3期73-76,共4页 Shanghai Medical & Pharmaceutical Journal
基金 上海市“医苑新星”青年医学人才培养资助计划。
关键词 临床药师 肺栓塞 抗凝治疗 药学监护 clinical pharmacists acute pulmonary embolism anticoagulant treatment pharmaceutical care
  • 相关文献

参考文献3

二级参考文献41

  • 1刘玉珍,张震宇,郭淑丽,何文,张晓蓉,王淑珍,刘崇东,李金凤,李琳.妇科盆腔手术后下肢深静脉血栓形成的临床研究[J].中华妇产科杂志,2006,41(2):107-110. 被引量:191
  • 2国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:79
  • 3陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 4陈新谦,金有豫,汤光,主编.新编药物学第[M].第17版.第50章:抗凝血药.北京:人民卫生出版社.
  • 5European Heart Rhythm Association, Camm AJ, Kirchhof P, et al. Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC).Guidelines for the management of atrial fibrillation[J]. Eur Heart J, 2010, 31(19): 2369-2429.
  • 6Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J]. N Engl J Med, 2011,365(10):883-891.
  • 7Granger CB, Alexander JH, McMurray J J, et al. Apixaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med, 2011,365(11):981-992.
  • 8Larsen TB, Lip GY. Warfarin or noveloral anticoagulants for atrial fibrillation?[J]. Lancet, 2014, 383(9921): 931-933.
  • 9January CT, Wann ST, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. Circulation, 2014, 130(23): 2071-2104.
  • 10Warfarin sodium tablet[OL]. DailyMed. http://daitymed.nlm.nih. gov/dailymed/druglnfo.cfm. 2014-8-14/2014-12-20.

共引文献1135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部